Análise de sobrevida e tolerabilidade à quimioterapia baseada em compostos platínicos em pacientes portadores de câncer de pulmão de células não-pequenas com idade superior a 70 anos

Costa, Guilherme Jorge.
São Paulo; s.n; 2007. [84] p. graf, tab.
Tese em Português | LILACS, Autarquia Hospitalar Municipal-Produção, Sec. Munic. Saúde SP, AHM-Produção Tatuapé, Sec. Munic. Saúde SP | ID: lil-642490

Documentos relacionados

  1. A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer.
  2. Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
  3. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
  4. Induction of immunogenic cell death by novel platinum-based anticancer agents.
  5. Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
  6. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data.
  7. Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.
  8. CUL4B increases platinum-based drug resistance in colorectal cancer through EMT: A study in its mechanism.
  9. Genetic polymorphisms in the mismatch repair pathway (MMR) genes contribute to hematological and gastrointestinal toxicity in North Indian lung cancer patients treated with platinum-based chemotherapy.
  10. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.